CIK 0001534133 · Non-accelerated filer<br>Smaller reporting company
CalciMedica, Inc.
Sign in to watch- Ticker
- CALC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452120079
- Phone
- 858-952-5500
- Business address
- 505 COAST BOULEVARD SOUTH, SUITE 307, LA JOLLA, CA, 92037
- Former names
- CalciMedica, Inc. /DE/, GRAYBUG VISION, INC., GRAYBUG, Inc., GRAYBUG LLC
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Other events
- 424B5 Offering Prospectus
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CHIEF BUSINESS OFFICER bought 2,500 shares at $3.07 ($7,675)
- 4 Open-market buy CHIEF BUSINESS OFFICER bought 3,400 shares at $2.68 ($9,105)
- 4 Open-market buy CHIEF BUSINESS OFFICER bought 5,000 shares at $3.12 ($15,600)
- 4 Open-market buy CHIEF BUSINESS OFFICER bought 2,343 shares at $3.15 ($7,378)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market buy CHIEF BUSINESS OFFICER bought 10,000 shares at an average $2.85 ($28,532)
- 4 Open-market buy CHIEF BUSINESS OFFICER bought 3,508 shares at $2.79 ($9,797)
- 4 Open-market buy CHIEF BUSINESS OFFICER bought 3,000 shares at an average $2.74 ($8,230)
- 4 Open-market buy Chief Medical Officer bought 9,563 shares at $2.82 ($26,962)
- 4 Open-market buy CHIEF BUSINESS OFFICER bought 5,076 shares at $2.90 ($14,709)
- 4 Open-market buy Chief Medical Officer bought 5,976 shares at an average $2.74 ($16,361)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 5 of 27 · 533 filings